Navigation Links
Nanosecond-scale release of stinging jellyfish nematocysts

By using an electronic ultra-high-speed camera, researchers have characterized the explosive discharge of stinging jellyfish nematocytes and show that this event represents one of the fastest cellular processes in nature. The research is reported by Thomas Holstein of the University of Heidelberg and his colleagues in the May 9th issue of Current Biology.

Nematocysts (also known as cnidocysts) of jellyfish and other cnidarians are giant exocytotic organelles of the stinging cells used for prey capture and defense. These miniature cellular weapons contain a cocktail of hemolytic and neurotoxic poisons, making some cnidarians the most venomous animals known. Injection of the toxins requires an effective release mechanism that breaks the physical barrier of the prey's outer-surface tissue. It was known already that a high pressure (15 MPa) drives nematocyst discharge, and that stylets can penetrate even thick crustacean shells. However, neither the kinetics nor the forces involved were known, simply because discharge is so fast that it had not been previously resolved by conventional high-speed imaging.

To clarify these issues, the researchers studied nematocyst discharge with an electronic framing-streak camera at a framing rate of 1,430,000 frames per second. They show discharge kinetics of nematocysts in Hydra to be as short as 700 nanoseconds, creating an acceleration of up to 5,410,000 g. The researchers calculate that although the accelerated mass is very small (~1 nanogram), a pressure generated at the site of impact is more than 7 GPa, which is in the range of that generated by some bullets, and sufficient to penetrate the cuticle of crustacean prey. The researchers propose that the high speed of discharge is caused by the release of energy stored in the stretched configuration of the collagen-polymer of the nematocyst capsule wall. This ingenious solution allows the cellular process of vesicle exocytosis to release kinetic energy in the nanoseco nd range by a powerful molecular spring mechanism.


'"/>

Source:Cell Press


Related biology news :

1. Inflammatory molecules released by pollen trigger allergies
2. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
3. GenMAPP 2.0 released
4. Agilent Technologies releases automated literature search tool for biology researchers
5. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
6. UCSD study clarifies insulins role in blocking release of energy in patients with type II diabetes
7. Public release of pig genomic sequences
8. Center releases new public survey on stem cells
9. 2005 AIDS figures released by WHO and UNAIDS
10. Researchers release new variety of asparagus
11. DOE JGI releases IMG 1.5 with curated archaeal genomes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
Breaking Biology Technology: